Literature DB >> 28368398

DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.

Z Shi1, F He1, M Chen1, L Hua1, W Wang1, S Jiao1, Z Zhou1,2.   

Abstract

TEA domain (TEAD) family transcription factors are key regulators in development, tissue homeostasis and cancer progression. TEAD4 acts as a critical downstream effector of the evolutionarily conserved Hippo signaling pathway. The well-studied oncogenic protein YAP forms a complex with TEAD4 to regulate gene transcription; so does the tumor suppressor VGLL4. Although it is known that TEAD proteins can bind promoter regions of target genes through the TEA domain, the specific and detailed mechanism of DNA recognition by the TEA domain remains partially understood. Here, we report the crystal structure of TEAD4 TEA domain in complex with a muscle-CAT DNA element. The structure revealed extensive interactions between the TEA domain and the DNA duplex involving both the major and minor grooves of DNA helix. The DNA recognition helix, α3 helix, determines the specificity of the TEA domain binding to DNA sequence. Structure-guided biochemical analysis identified two major binding sites on the interface of the TEA domain-DNA complex. Mutation of TEAD4 at either site substantially decreases its occupancy on the promoter region of target genes, and largely impaired YAP-induced TEAD4 transactivation and target gene transcription, leading to inhibition of growth and colony formation of gastric cancer cell HGC-27. Collectively, our work provides a structural basis for understanding the regulatory mechanism of TEAD-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28368398     DOI: 10.1038/onc.2017.24

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity.

Authors:  Tong Guo; Yi Lu; Peixue Li; Meng-Xin Yin; Dekang Lv; Wenjing Zhang; Huizhen Wang; Zhaocai Zhou; Hongbin Ji; Yun Zhao; Lei Zhang
Journal:  Cell Res       Date:  2013-09-03       Impact factor: 25.617

Review 2.  The many faces of the helix-turn-helix domain: transcription regulation and beyond.

Authors:  L Aravind; Vivek Anantharaman; Santhanam Balaji; M Mohan Babu; Lakshminarayan M Iyer
Journal:  FEMS Microbiol Rev       Date:  2005-04       Impact factor: 16.408

3.  ATTS, a new and conserved DNA binding domain.

Authors:  A Andrianopoulos; W E Timberlake
Journal:  Plant Cell       Date:  1991-08       Impact factor: 11.277

Review 4.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

5.  Structural insights into the YAP and TEAD complex.

Authors:  Ze Li; Bin Zhao; Ping Wang; Fei Chen; Zhenghong Dong; Huirong Yang; Kun-Liang Guan; Yanhui Xu
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  A conserved CATTCCT motif is required for skeletal muscle-specific activity of the cardiac troponin T gene promoter.

Authors:  J H Mar; C P Ordahl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 8.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

9.  Towards automated crystallographic structure refinement with phenix.refine.

Authors:  Pavel V Afonine; Ralf W Grosse-Kunstleve; Nathaniel Echols; Jeffrey J Headd; Nigel W Moriarty; Marat Mustyakimov; Thomas C Terwilliger; Alexandre Urzhumtsev; Peter H Zwart; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16

10.  Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway.

Authors:  PuiYee Chan; Xiao Han; Baohui Zheng; Michael DeRan; Jianzhong Yu; Gopala K Jarugumilli; Hua Deng; Duojia Pan; Xuelian Luo; Xu Wu
Journal:  Nat Chem Biol       Date:  2016-02-22       Impact factor: 15.040

View more
  16 in total

1.  Dual function of VGLL4 in muscle regeneration.

Authors:  Xue Feng; Zuoyun Wang; Fei Wang; Tiantian Lu; Jinjin Xu; Xueyan Ma; Jinhui Li; Lingli He; Wenxiang Zhang; Sheng Li; Wenjun Yang; Shu Zhang; Gaoxiang Ge; Yun Zhao; Ping Hu; Lei Zhang
Journal:  EMBO J       Date:  2019-07-22       Impact factor: 11.598

2.  Effect of TEAD4 on multilineage differentiation of muscle-derived stem cells.

Authors:  Jinze Wang; Feixu Zhang; Huidi Yang; Huikuan Wu; Rong Cui; Yunjie Zhao; Cuihua Jiao; Xianxin Wang; Xin Liu; Liqiong Wu; Guangpeng Li; Xia Wu
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

3.  Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes.

Authors:  Haofei Wang; Benjamin Keepers; Yunzhe Qian; Yifang Xie; Marazzano Colon; Jiandong Liu; Li Qian
Journal:  Cell Stem Cell       Date:  2022-10-06       Impact factor: 25.269

4.  RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling.

Authors:  Sunkyung Choi; Hyo Seong Lee; Namjoon Cho; Inyoung Kim; Seongmin Cheon; Chungoo Park; Eun-Mi Kim; Wantae Kim; Kee K Kim
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

5.  Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.

Authors:  Yannick Mesrouze; Marco Meyerhofer; Fedir Bokhovchuk; Patrizia Fontana; Catherine Zimmermann; Typhaine Martin; Clara Delaunay; Aude Izaac; Joerg Kallen; Tobias Schmelzle; Dirk Erdmann; Patrick Chène
Journal:  Protein Sci       Date:  2017-11-11       Impact factor: 6.725

Review 6.  Regulation of the Hippo Pathway Transcription Factor TEAD.

Authors:  Kimberly C Lin; Hyun Woo Park; Kun-Liang Guan
Journal:  Trends Biochem Sci       Date:  2017-09-27       Impact factor: 13.807

7.  A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.

Authors:  Chi Zhu; Li Li; Zhao Zhang; Mingjun Bi; Hu Wang; Wenyue Su; Karen Hernandez; Pingping Liu; Junqiang Chen; Mingqiu Chen; Tim Hui-Ming Huang; Lizhen Chen; Zhijie Liu
Journal:  Mol Cell       Date:  2019-07-11       Impact factor: 17.970

8.  Targeting IRF3 as a YAP agonist therapy against gastric cancer.

Authors:  Shi Jiao; Jingmin Guan; Min Chen; Wenjia Wang; Chuanchuan Li; Yugong Wang; Yunfeng Cheng; Zhaocai Zhou
Journal:  J Exp Med       Date:  2018-01-16       Impact factor: 14.307

Review 9.  Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors.

Authors:  Jeffrey K Holden; Christian N Cunningham
Journal:  Cancers (Basel)       Date:  2018-03-20       Impact factor: 6.639

Review 10.  YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

Authors:  Janine S A Warren; Yuxuan Xiao; John M Lamar
Journal:  Cancers (Basel)       Date:  2018-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.